Recent advances in the synthesis of Quinazoline analogues as Anti-TB agents

被引：40

作者：

Dutta, Apurba ^{[1
]}

Sarma, Diganta ^{[1
]}

机构：

[1] Dibrugarh Univ, Dept Chem, Dibrugarh 786004, Assam, India

来源：

TUBERCULOSIS | 2020年 / 124卷

关键词：

Mycobacterium tuberculosis; Anti-tubercular drugs; Heterocyclic chemistry; Quinazoline analogues; Structure-activity relationship; BIOLOGICAL EVALUATION; EFFICIENT SYNTHESIS; ADHATODA-VASICA; DERIVATIVES; CATALYST; DESIGN; 1,2-DIHYDROQUINAZOLIN-4(3H)-ONES; ALDEHYDES; SAMARIUM; WATER;

D O I：

10.1016/j.tube.2020.101986

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Quinazoline analogues are one of the important nitrogen containing heterocycles that have significant bioactivity as well as found in a plethora of natural products. Tuberculosis is one of the serious universal health threats caused by Mycobacterium tuberculosis (MTB) and primarily affects the lungs. Due to their significant bioactivity and natural occurrences of quinazolines, researchers are trying to synthesize new quinazoline analogues which may have significant potency against tuberculosis. This particular review summarizes recent development of different types of quinazoline bearing analogues as anti-tubercular (anti-TB) agents and their synthesis with structure-activity relationship.

引用

页数：19

共 50 条

[41] Possible Protective Effect of Chalcone Analogues Against Anti-Tb Drugs Induced Hepatocellular Damage in Rats
Kalia, Shikha
Sharma, Gargi
Sapra, Sameer
Goyal, Rohit
INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S85 - S85
[42] Molecular modeling studies and anti-TB activity of trisubstituted indolizine analogues; molecular docking and dynamic inputs
Khedr, Mohammed A.
Pillay, Melendhran
Chandrashekharappa, Sandeep
Chopra, Deepak
Aldhubiab, Bandar E.
Attimarad, Mahesh
Alwassil, Osama Ibrahim
Mlisana, Koleka
Odhav, Bharti
Venugopala, Katharigatta N.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2018, 36 (08): : 2163 - 2178
[43] Synthesis, Molecular docking, Antioxidant, Anti-TB, and Potent MCF-7 Anticancer Studies of Novel Aryl-carbohydrazide Analogues
Thorat, Bapu R.
Mali, Suraj N.
Wagh, Rahul R.
Yamgar, Ramesh S.
CURRENT COMPUTER-AIDED DRUG DESIGN, 2022, 18 (04) : 247 - 257
[44] PREVENTION OF RESISTANCE TO NEW ANTI-TB DRUGS
Varudkar, H. G.
LUNG INDIA, 2005, 22 (04) : 142 - 145
[45] Counting current anti-TB drug candidates
不详
LEPROSY REVIEW, 2002, 73 (01) : 102 - 102
[46] Chiron licenses novel anti-TB drug
不详
CHEMISTRY IN BRITAIN, 2002, 38 (04) : 10 - 10
[47] Recent Advances in Metal-Catalyzed Approaches for the Synthesis of Quinazoline Derivatives
Nandwana, Nitesh K.
Patel, Om P. S.
Mehra, Manish K.
Kumar, Anil
Salvino, Joseph M.
MOLECULES, 2024, 29 (10):
[48] Global overview of new anti-TB compounds
Doi, N.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S17 - S18
[49] Quinolinyl Pyrimidines: Potent Inhibitors of NDH-2 as a Novel Class of Anti-TB Agents
Shirude, Pravin S.
Paul, Beena
Choudhury, Nilanjana Roy
Kedari, Chaitanya
Bandodkar, Balachandra
Ugarkar, Bheemarao G.
ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (09): : 736 - 740
[50] Recent Advances in the Synthesis of Tamoxifen and Analogues in Medicinal Chemistry
Tandon, Nitin
Luxami, Vijay
Tandon, Runjhun
Paul, Kamaldeep
ASIAN JOURNAL OF ORGANIC CHEMISTRY, 2020, 9 (10) : 1432 - 1465

← 1 2 3 4 5 →